Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
591 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07278362 | Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance | not yet recruiting | Phase 4 | 35 | University of MiamiOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT06226129 | Gadopiclenol in Contrast Enhanced MRI of the Prostate | suspended | Phase 4 | 150 | Columbia UniversityOTHER | 1 | Jul 20, 2026 | clinicaltrials |
| Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease |
| not yet recruiting |
| Phase 4 |
| 50 |
| James BayleyOTHER |
| 1 |
| Jul 20, 2026 |
| clinicaltrials |
| NCT02162849 | Reward Sensitivity and Pharmacotherapy for Smoking Cessation | active not recruiting | Phase 4 | 204 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT03023631 | Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant | active not recruiting | Phase 4 | 48 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT06289673 | Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma | recruiting | Phase 4 | 850 | St. Jude Children's Research HospitalOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT02422745 | COcoa Supplement and Multivitamin Outcomes Study(COSMOS) | completed | Phase 4 | 21,442 | Brigham and Women's HospitalOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT06604442 | Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy | completed | Phase 4 | 62 | Blue Earth DiagnosticsINDUSTRY | 1 | Jul 13, 2026 | clinicaltrials |
| NCT07220967 | A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement | recruiting | Phase 4 | 392 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 10, 2026 | clinicaltrials |
| NCT04246697 | Multimodal Pain Study in Free Flap Patients | completed | Phase 4 | 30 | University of Kansas Medical CenterOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT06169371 | Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)(BRE-09) | recruiting | Phase 4 | 50 | University of Illinois at ChicagoOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT06183437 | The STOP-MED CTRCD Trial(STOP-MED CTRCD) | recruiting | Phase 4 | 335 | Dinesh ThavendiranathanOTHER | 6 | Jul 7, 2026 | clinicaltrials |
| NCT06562543 | A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer | recruiting | Phase 4 | 78 | TakedaINDUSTRY | 2 | Jul 7, 2026 | clinicaltrials |
| NCT04877522 | Asciminib Roll-over Study | recruiting | Phase 4 | 347 | Novartis PharmaceuticalsINDUSTRY | 29 | Jul 6, 2026 | clinicaltrials |
| NCT06461442 | Efficacy and Safety of Cryotherapy Versus 5-Fluorouracil in the Treatment of Actinic Keratosis | enrolling by invitation | Phase 4 | 73 | University of California, DavisOTHER | 1 | Jul 6, 2026 | clinicaltrials |
| NCT07220356 | C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics | active not recruiting | Phase 4 | 30 | Johns Hopkins UniversityOTHER | 1 | Jul 6, 2026 | clinicaltrials |
| NCT05183126 | Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer | recruiting | Phase 4 | 22 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT05376878 | An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis | recruiting | Phase 4 | 10 | City of Hope Medical CenterOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT06057402 | Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)(MagnetisMM15) | recruiting | Phase 4 | 80 | PfizerINDUSTRY | 7 | Jul 1, 2026 | clinicaltrials |
| NCT05722925 | Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET | active not recruiting | Phase 4 | 50 | OHSU Knight Cancer InstituteOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT07287826 | Using a Steroid Mouthwash to Prevent Mouth Sores During Chemotherapy(SMILE) | recruiting | Phase 4 | 45 | Woman'sOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT06016855 | Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors | recruiting | Phase 4 | 6 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07664956 | Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy | not yet recruiting | Phase 4 | 36 | Christiana Care Health ServicesOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07133074 | Allergy Delabeling in Antibiotic Stewardship - Intervention(RENEW-IN) | recruiting | Phase 4 | 3,800 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT03096418 | Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response | recruiting | Phase 4 | 50 | University of Wisconsin, MadisonOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT04296305 | Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain | active not recruiting | Phase 4 | 84 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT07405086 | Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study | recruiting | Phase 4 | 160 | OHSU Knight Cancer InstituteOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT06162377 | Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study. | recruiting | Phase 4 | 25 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT05538689 | Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)(SOUL) | withdrawn | Phase 4 | 0 | University of ChicagoOTHER | 1 | Jun 5, 2026 | clinicaltrials |
| NCT07084948 | Inhibition of HBV Replication and Biological Reversal of Cirrhosis (F3-F4) and HCC by Flavonoids(Flavonoids) | completed | Phase 4 | 134 | Trieu, Nguyen Thi, M.D.INDIV | 2 | Jun 5, 2026 | clinicaltrials |
| NCT05183828 | Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer | terminated | Phase 4 | 62 | University of WashingtonOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT05803941 | Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer | recruiting | Phase 4 | 700 | Novartis PharmaceuticalsINDUSTRY | 11 | Jun 4, 2026 | clinicaltrials |
| NCT02875314 | HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors | active not recruiting | Phase 4 | 250 | Parth PatelOTHER | 3 | Jun 3, 2026 | clinicaltrials |
| NCT07286188 | Effect of Misoprostol on Fluid Deficit Volume in Hysteroscopic Myomectomy | recruiting | Phase 4 | 40 | Northwestern UniversityOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT06370000 | Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality(REMAIN1) | recruiting | Phase 4 | 12 | Virginia Commonwealth UniversityOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT07605897 | Assessment of Safety, Quality, and Acceptance of a Bowel Preparation Using a Food Kit With Laxatives | completed | Phase 4 | 57 | Joseph SpataroFED | 1 | May 26, 2026 | clinicaltrials |
| NCT04265430 | Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors | recruiting | Phase 4 | 425 | M.D. Anderson Cancer CenterOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT04764292 | Screening Contrast-Enhanced Mammography as an Alternative to MRI(SCEMAM) | completed | Phase 4 | 615 | Wendie BergOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT06733350 | Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance | recruiting | Phase 4 | 600 | Roswell Park Cancer InstituteOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT07587749 | Skin Subs vs Secondary Intention | not yet recruiting | Phase 4 | 50 | Baylor Research InstituteOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT06574009 | Better Options for Chronic Cancer Pain | recruiting | Phase 4 | 294 | VA Office of Research and DevelopmentFED | 1 | May 11, 2026 | clinicaltrials |
| NCT07575230 | Suzetrigine vs Norco-postoperative Mohs Pain | enrolling by invitation | Phase 4 | 75 | Baylor Research InstituteOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT04745910 | Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome | completed | Phase 4 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT06169735 | Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation | terminated | Phase 4 | 417 | University of Alabama at BirminghamOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT04235257 | Intradermal, Fractional Dose of HPV Vaccines: | active not recruiting | Phase 4 | 40 | University of WashingtonOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT05291871 | Immunogenicity of Fractional Dose of the HPV Vaccines | active not recruiting | Phase 4 | 92 | University of WashingtonOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT03173092 | A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM) | terminated | Phase 4 | 141 | TakedaINDUSTRY | 1 | May 4, 2026 | clinicaltrials |
| NCT04604509 | Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial | recruiting | Phase 4 | 2,010 | M.D. Anderson Cancer CenterOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT04206813 | An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen | active not recruiting | Phase 4 | 352 | Boston Medical CenterOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT06625047 | Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy | completed | Phase 4 | 30 | Mayo ClinicOTHER | 1 | Apr 29, 2026 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials